| abstract |
(―)-1-(Benzofuran-2-yl)-2-propylaminopentane that contains no (+)-isomer substantiallynand shown by the following formula, and the pharmaceutically acceptable acid salts arendisclosed. These compounds have excellent CAE effect (catecholaminergic activity enhancerneffect) which is the enhancing action of neurotransmitter catecholamine release, and arenuseful as psychotropic composition, antidepressants, composition for treating Parkinson'sndisease and/or Alzheimer's disease. |